Abbott Deal Ends Appeal After $495M Baby Formula Trial Loss
Abbott Laboratories Inc. has struck a deal with a family that won a $495 million judgment against the U.S. pharmaceutical company in a bellwether trial over claims that its baby formula...To view the full article, register now.
Already a subscriber? Click here to view full article